Publications

1. Singh B. In women with epilepsy, use of valproate in the second half of pregnancy was linked to autism in offspring Ann Intern Med.. 2024; 177(7):JC82.
   
2. Singh B, Kung S, Poppe KA, Brown SL, Erickson C, Hale AM, Johnson BL, Jones KL, Pazdernik VK, Schak KM, Betcher HK, Moore KM, Ozerdem A, Veldic M, Frye MA, Bobo WV. Partial wake therapy and luminotherapy as an adjunct to usual care in hospitalized patients with depression - a pilot study. Psychiatry Res 2024 Jul; 337:115921 Epub 2024 Apr 25
   View PubMed
3. Seshadri A, Prokop LJ, Singh B. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. J Affect Disord. 2024 Jul 1; 356:379-384 Epub 2024 Mar 26
   View PubMed
4. Singh B, Kung S, Vande Voort JL. Intravenous (IV) ketamine versus intranasal esketamine for depression- Advantage IV ketamine? J Affect Disord 2024 Jul 1; 356:564-567 Epub 2024 Apr 22
   View PubMed
5. Kumar R, Nunez NA, Joshi N, Joseph B, Verde A, Seshadri A, Cuellar Barboza AB, Prokop LJ, Medeiros GC, Singh B. Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review. Bipolar Disord. 2024 Jun; 26 (4):321-330 Epub 2024 Feb 07
   View PubMed
6. Ercis M, Ozerdem A, Veldic M, Singh B, Coombes BJ, Biernacka JM, Lazaridis KN, Frye MA. Measuring the exposome in bipolar disorder. Bipolar Disord. 2024 May 1 Epub 2024 May 01
   View PubMed
7. Singh B, Parikh SV, Voort JLV, Pazdernik VK, Achtyes ED, Goes FS, Yocum AK, Nykamp L, Becerra A, Smart L, Greden JF, Bobo WV, Frye MA, Burdick KE, Ryan KA. Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial. Psychiatry Res. 2024 May; 335:115829 Epub 2024 Feb 28
   View PubMed
8. Ghafouri M, Duque L, Rodriguez LP, Philbrick KL, Savica R, Pazdernik VK, Port JD, Rummans TA, Singh B. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study. Schizophr Res 2024 May; 267:138-140 Epub 2024 Mar 26
   View PubMed
9. Singh B, Vande Voort JL, Pazdernik VK, Frye MA, Kung S. Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine. J Affect Disord. 2024 Apr 15; 351:534-540 Epub 2024 Jan 30
   View PubMed
10. Cavalcanti S, Lopez OA, Kung S, Vande Voort JL, Somers K, Frye MA, Singh B. A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression. J Clin Psychopharmacol. 2024 Apr 10 [Epub ahead of print]
    View PubMed
11. Duque L, Ghafouri M, Nunez NA, Ospina JP, Philbrick KL, Port JD, Savica R, Prokop LJ, Rummans TA, Singh B. Functional neuroimaging in patients with catatonia: A systematic review. J Psychosom Res. 2024 Apr; 179:111640 Epub 2024 Mar 11
    View PubMed
12. Nunez NA, Jezzini-Martinez S, Ho AM, Gardea-Resendez M, Prokop LJ, Singh B, Robledo-Atilano PM, Romo-Nava F, Veldic M, McElroy SL, Frye MA, Cuellar-Barboza AB. Candidate gene polymorphisms and clinical implications of the use of psychostimulants in adults with mood or attentional deficit disorders: A systematic review Biomarkers in Neuropsychiatry. 2024.
    
13. Patarroyo-Rodriguez L, Pazdernik V, Vande Voort JL, Kung S, Singh B. Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression. J Affect Disord. 2024 Mar 15; 349:272-276 Epub 2024 Jan 08
    View PubMed
14. Parikh SV, Vande Voort JL, Yocum AK, Achtyes E, Goes FS, Nykamp L, Singh B, Lopez-Vives D, Sera CE, Maixner D, Tarnal V, Severe J, Bartek S, Tye SJ, Rico J, Stoppel CJ, Becerra A, Smart L, Miller CR, Frye MA, Greden JF, Bobo WV. Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression. J Affect Disord. 2024 Mar 1; 348:143-151 Epub 2023 Dec 22
    View PubMed
15. Nunez NA, Coombes BJ, Beaupre LM, Ozerdem A, Resendez MG, Romo-Nava F, Bond DJ, Veldic M, Singh B, Moore KM, Betcher HK, Kung S, Prieto ML, Fuentes M, Ercis M, Miola A, Sanchez Ruiz JA, Jenkins G, Batzler A, Leung JG, Cuellar-Barboza A, Tye SJ, McElroy SL, Biernacka JM, Frye MA. Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder. Transl Psychiatry. 2024 Feb 13; 14 (1):93
    View PubMed
16. Singh B, Yocum AK, Strawbridge R, Burdick KE, Millett CE, Peters AT, Sperry SH, Fico G, Vieta E, Verdolini N, Godin O, Leboyer M, Etain B, Tso IF, Coombes BJ, McInnis MG, Nierenberg AA, Young AH, Ashton MM, Berk M, Williams LJ, Keramatian K, Yatham LN, Overs BJ, Fullerton JM, Roberts G, Mitchell PB, Andreassen OA, Andreazza AC, Zandi PP, Pham D, Biernacka JM, Frye MA, FACE-BD Collaborators, The Global Bipolar Cohort Collaborative. Patterns of pharmacotherapy for bipolar disorder: A GBC survey. Bipolar Disord. 2024 Feb; 26 (1):22-32 Epub 2023 July 18
    View PubMed
17. Gargano MA, Matentzoglu N, Coleman B, Addo-Lartey EB, Anagnostopoulos AV, Anderton J, Avillach P, Bagley AM, Bakstein E, Balhoff JP, Baynam G, Bello SM, Berk M, Bertram H, Bishop S, Blau H, Bodenstein DF, Botas P, Boztug K, Cady J, Callahan TJ, Cameron R, Carbon SJ, Castellanos F, Caufield JH, Chan LE, Chute CG, Cruz-Rojo J, Dahan-Oliel N, Davids JR, de Dieuleveult M, de Souza V, de Vries BBA, de Vries E, DePaulo JR, Derfalvi B, Dhombres F, Diaz-Byrd C, Dingemans AJM, Donadille B, Duyzend M, Elfeky R, Essaid S, Fabrizzi C, Fico G, Firth HV, Freudenberg-Hua Y, Fullerton JM, Gabriel DL, Gilmour K, Giordano J, Goes FS, Moses RG, Green I, Griese M, Groza T, Gu W, Guthrie J, Gyori B, Hamosh A, Hanauer M, Hanusova K, He YO, Hegde H, Helbig I, Holasova K, Hoyt CT, Huang S, Hurwitz E, Jacobsen JOB, Jiang X, Joseph L, Keramatian K, King B, Knoflach K, Koolen DA, Kraus ML, Kroll C, Kusters M, Ladewig MS, Lagorce D, Lai MC, Lapunzina P, Laraway B, Lewis-Smith D, Li X, Lucano C, Majd M, Marazita ML, Martinez-Glez V, McHenry TH, McInnis MG, McMurry JA, Mihulova M, Millett CE, Mitchell PB, Moslerova V, Narutomi K, Nematollahi S, Nevado J, Nierenberg AA, Cajbikova NN, Nurnberger JI Jr, Ogishima S, Olson D, Ortiz A, Pachajoa H, Perez de Nanclares G, Peters A, Putman T, Rapp CK, Rath A, Reese J, Rekerle L, Roberts AM, Roy S, Sanders SJ, Schuetz C, Schulte EC, Schulze TG, Schwarz M, Scott K, Seelow D, Seitz B, Shen Y, Similuk MN, Simon ES, Singh B, Smedley D, Smith CL, Smolinsky JT, Sperry S, Stafford E, Stefancsik R, Steinhaus R, Strawbridge R, Sundaramurthi JC, Talapova P, Tenorio Castano JA, Tesner P, Thomas RH, Thurm A, Turnovec M, van Gijn ME, Vasilevsky NA, Vlckova M, Walden A, Wang K, Wapner R, Ware JS, Wiafe AA, Wiafe SA, Wiggins LD, Williams AE, Wu C, Wyrwoll MJ, Xiong H, Yalin N, Yamamoto Y, Yatham LN, Yocum AK, Young AH, Yuksel Z, Zandi PP, Zankl A, Zarante I, Zvolsky M, Toro S, Carmody LC, Harris NL, Munoz-Torres MC, Danis D, Mungall CJ, Kohler S, Haendel MA, Robinson PN. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. 2024 Jan 5; 52 (D1):D1333-D1346
    View PubMed
18. Nunez NA, Joseph B, Kumar R, Douka I, Miola A, Prokop LJ, Mickey BJ, Singh B. An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis. Brain Sci. 2023 Dec 2; 13 (12) Epub 2023 Dec 02
    View PubMed
19. Joseph B, Nunez NA, Kung S, Vande Voort JL, Pazdernik VK, Schak KM, Boehm SM, Carpenter B, Johnson EK, Malyshev G, Smits N, Adewunmi DO, Brown SK, Singh B. Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2023, 16, 1164. Pharmaceuticals (Basel). 2023 Nov 7; 16 (11) Epub 2023 Nov 07
    View PubMed
20. Nunez NA, Coombes BJ, Melhuish Beaupre L, Romo-Nava F, Gardea-Resendez M, Ozerdem A, Veldic M, Singh B, Sanchez Ruiz JA, Cuellar-Barboza A, Leung JG, Prieto ML, McElroy SL, Biernacka JM, Frye MA. Antidepressant-Associated Treatment Emergent Mania: A Meta-Analysis to Guide Risk Modeling Pharmacogenomic Targets of Potential Clinical Value. J Clin Psychopharmacol. 2023 Aug 16; 43 (5):428-33 [Epub ahead of print]
    View PubMed
21. Joseph B, Nunez NA, Kung S, Vande Voort JL, Pazdernik VK, Schak KM, Boehm SM, Carpenter B, Johnson EK, Malyshev G, Smits N, Adewunmi DO, Brown SK, Singh B. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals (Basel). 2023 Aug 16; 16 (8)
    View PubMed
22. Miola A, Alvarez-Villalobos NA, Ruiz-Hernandez FG, De Filippis E, Veldic M, Prieto ML, Singh B, Sanchez Ruiz JA, Nunez NA, Resendez MG, Romo-Nava F, McElroy SL, Ozerdem A, Biernacka JM, Frye MA, Cuellar-Barboza AB. Insulin resistance in bipolar disorder: A systematic review of illness course and clinical correlates. J Affect Disord. 2023 Aug 1; 334:1-11 Epub 2023 Apr 21
    View PubMed
23. Romo-Nava F, Blom T, Cuellar-Barboza AB, Barrera FJ, Miola A, Mori NN, Prieto ML, Veldic M, Singh B, Gardea-Resendez M, Nunez NA, Ozerdem A, Biernacka JM, Frye MA, McElroy SL. Clinical characterization of patients with bipolar disorder and a history of asthma: An exploratory study. J Psychiatr Res. 2023 Aug; 164:8-14 Epub 2023 June 03
    View PubMed
24. Kumar R, LeMahieu AM, Stan MN, Seshadri A, Ozerdem A, Pazdernik VK, Haynes TL, Daugherty DH 3rd, Sundaresh V, Veldic M, Croarkin PE, Frye MA, Singh B. The Association Between Thyroid Stimulating Hormone and Depression: A Historical Cohort Study. Mayo Clin Proc. 2023 Jul; 98 (7):1009-1020
    View PubMed
25. Singh B, Vande Voort JL, Riva-Posse P, Pazdernik VM, Frye MA, Tye SJ. Ketamine-Associated Change in Anhedonia and mTOR Expression in Treatment-Resistant Depression. Biol Psychiatry 2023 Jun 15; 93 (12):e65-e68 Epub 2023 Jan 25
    View PubMed
26. Singal P, Nunez NA, Joseph B, Hassett LC, Seshadri A, Singh B. Efficacy and Safety of Clonidine in the Treatment of Acute Mania in Bipolar Disorder: A Systematic Review. Brain Sci. 2023 Mar 25; 13 (4)
    View PubMed
27. Ercis M, Ozerdem A, Singh B. When and How to Use Lithium Augmentation for Treating Major Depressive Disorder. J Clin Psychiatry. 2023 Mar 08; 84(2).
    View PubMed
28. Kumar R, Garzon J, Yuruk D, Hassett LC, Saliba M, Ozger C, Oztosun C, Ahern K, Athreya AP, Singh B, Croarkin PE, Vande Voort JL. Efficacy and safety of lamotrigine in pediatric mood disorders: A systematic review. Acta Psychiatr Scand. 2023 Mar; 147 (3):248-256 Epub 2022 Sept 21
    View PubMed
29. Gardea-Resendez M, Coombes BJ, Veldic M, Tye SJ, Romo-Nava F, Ozerdem A, Prieto ML, Cuellar-Barboza A, Nunez NA, Singh B, Pendegraft RS, Miola A, McElroy SL, Biernacka JM, Morava E, Kozicz T, Frye MA. Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania. Mol Psychiatry. 2023 Mar; 28 (3):1020-1026 Epub 2022 Dec 13
    View PubMed
30. Pahwa M, Kucuker MU, Ho MC, Puspitasari A, Moore KM, Betcher HK, Frye MA, Singh B, Ozerdem A, Veldic M. Cardiometabolic and endocrine comorbidities in women with bipolar disorder: A systematic review. J Affect Disord. 2023 Feb 15; 323:841-859 Epub 2022 Dec 17
    View PubMed
31. Singh B, Kung S, Pazdernik V, Schak KM, Geske J, Schulte PJ, Frye MA, Vande Voort JL. Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study. J Clin Psychiatry. 2023 Feb 1; 84 (2) Epub 2023 Feb 01
    View PubMed
32. Joseph B, Nunez NA, Pazdernik V, Kumar R, Pahwa M, Ercis M, Ozerdem A, Cuellar-Barboza AB, Romo-Nava F, McElroy SL, Coombes BJ, Biernacka JM, Stan MN, Frye MA, Singh B. Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study. Brain Sci. 2023 Jan 12; 13(1).
    View PubMed
33. Kumar R, Joseph B, Pazdernik VM, Geske J, Nuñez NA, Pahwa M, Kashani KB, Veldic M, Betcher HK, Moore KM, Croarkin PE, Ozerdem A, Cuellar-Barboza AB, McElroy SL, Biernacka JM, Frye MA, Singh B. Real-World Clinical Practice Among Patients With Bipolar Disorder and Chronic Kidney Disease on Long-term Lithium Therapy. J Clin Psychopharmacol. 2023 Jan-Feb 01; 43(1):6-11.
    View PubMed
34. Seshadri A, Sundaresh V, Prokop LJ, Singh B. Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review. Brain Sci. 2022 Nov 14; 12 (11)
    View PubMed
35. Leung JG, de Leon J, Frye MA, Singh B, Cotes RO, McElroy SL. The Modernization of Clozapine: A Recapitulation of the Past in the United States and the View Forward. J Clin Psychopharmacol. 2022 Sep 16 Epub 2022 Sept 16
    View PubMed
36. Medeiros GC, Gould TD, Prueitt WL, Nanavati J, Grunebaum MF, Farber NB, Singh B, Selvaraj S, Machado-Vieira R, Achtyes ED, Parikh SV, Frye MA, Zarate CA Jr, Goes FS. Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis. Mol Psychiatry 2022 Sep; 27 (9):3658-3669 Epub 2022 June 27
    View PubMed
37. Singh B, Sundaresh V. Thyroid Hormone Use in Mood Disorders: Revisiting the Evidence. J Clin Psychiatry. 2022 Aug 15; 83 (5)
    View PubMed
38. Singh B, MahmoudianDehkordi S, Voort JLV, Han X, Port JD, Frye MA, Kaddurah-Daouk R, Mood Disorders Precision Medicine Consortium (MDPMC). Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study. Psychiatry Res. 2022 Aug; 314:114655 Epub 2022 May 28
    View PubMed
39. Gardea-Resendez M, Winham SJ, Romo-Nava F, Cuellar-Barboza A, Clark MM, Andreazza AC, Cabello-Arreola A, Veldic M, Bond DJ, Singh B, Prieto ML, Nunez NA, Betcher H, Moore KM, Blom T, Colby C, Pendegraft RS, Kelpin SS, Ozerdem A, Miola A, De Filippis E, Biernacka JM, McElroy SL, Frye MA. Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies. J Affect Disord. 2022 Aug 1; 310:150-155 Epub 2022 May 08
    View PubMed
40. Singh B, Vande Voort JL, Frye MA, Kung S. Can ketamine be a safe option for treatment-resistant bipolar depression? Expert Opin Drug Saf 2022 Jun; 21 (6):717-720 Epub 2022 Feb 28
    View PubMed
41. Park JH, Nuñez NA, Gardea-Resendez M, Gerberi DJ, Breitinger S, Veldic M, Frye MA, Singh B. Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2022 May 31; 52(2):45-72.
    View PubMed
42. Grzenda A, Veldic M, Jia Y, McElroy SL, Bond DJ, Geske JR, Ozerdem A, Singh B, Biernacka JM, Choi DS, Frye MA. Differences in perceived life stress in bipolar I and II disorder: Implications for future epigenetic quantification Personalized Medicine in Psychiatry. 2022.
    
43. Nunez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, Veldic M, Seshadri A, Biernacka JM, Frye MA, Wang Z, Singh B. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. J Affect Disord. 2022 Apr 1; 302:385-400 Epub 2022 Jan 02
    View PubMed
44. Singh B, Kung S, Schak KM, Bobo WV, Frye MA, Vande Voort JL. Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression. CNS Spectr. 2022 Apr; 27 (2):232
    View PubMed
45. Hu Y, Nassan M, Singh B, Croarkin PE, Kung S. Response rate underreports improvement in patients with major depressive disorder and comorbidities treated with repetitive transcranial magnetic stimulation (rTMS) Psychiatry Research Communications. 03/08/2022; 2(2).
    
46. Gardea-Resendez M, Taylor-Desir MJ, Romo-Nava F, Bond D, Vallender EJ, Cuellar-Barboza AB, Prieto ML, Nunez N, Veldic M, Ozerdem A, Singh B, Markota M, Colby CL, Coombes BJ, Biernacka JM, McElroy SL, Frye MA. Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder. J Clin Psychopharmacol. 2022 Mar-Apr 01; 42(2):159-162.
    View PubMed
47. Singh B, Port JD, Pazdernik V, Coombes BJ, Vande Voort JL, Frye MA. Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: A pilot study. Psychiatry Res Neuroimaging 2022 Mar; 320:111432 Epub 2021 Dec 24
    View PubMed
48. Nunez NA, Coombes BJ, Romo-Nava F, Bond DJ, Vande Voort J, Croarkin PE, Leibman N, Gardea Resendez M, Veldic M, Betcher H, Singh B, Colby C, Cuellar-Barboza A, Prieto M, Moore KM, Ozerdem A, McElroy SL, Frye MA, Biernacka JM. Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder. Front Psychiatry. 2022; 13:884217 Epub 2022 Apr 14
    View PubMed
49. Elsayed OH, Ercis M, Pahwa M, Singh B. Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions. Neuropsychiatr Dis Treat. 2022; 18:2927-2943. Epub 2022 Dec 16.
    View PubMed
50. Romo-Nava F, Blom T, Cuellar-Barboza AB, Awosika OO, Martens BE, Mori NN, Colby CL, Prieto ML, Veldic M, Singh B, Gardea-Resendez M, Nunez NA, Ozerdem A, Biernacka JM, Frye MA, McElroy SL. Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity. J Affect Disord. 2021 Dec 1; 295:156-162 Epub 2021 Aug 23
    View PubMed
51. Pease E, Singh B, Ziegelmann M, Betcher H. Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder. Psychopharmacol Bull. 2021 Nov 3; 51 (4):117-121
    View PubMed
52. Pahwa M, Joseph B, Nunez NA, Jenkins GD, Colby CL, Kashani KB, Marin Veldic Veldic, Marin Veldic Veldic, Moore KM, Betcher HK, Ozerdem A, Cuellar-Barboza AB, McElroy SL, Biernacka JM, Frye MA, Singh B. Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study. Bipolar Disord. 2021 Nov; 23 (7):715-723 Epub 2021 Mar 11
    View PubMed
53. Nunez NA, Sola C, Kung S, Singh B, Ozerdem A, Veldic M, Croarkin PE, Moore KM, Betcher HK, Vande JL, Geske JR, Biernacka JM, Rummans TA, Bahn RS, Frye MA. Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders Personalized Medicine in Psychiatry. 2021; 29-30.
    
54. Kumar R, Nunez NA, Prokop LJ, Veldic M, Betcher H, Singh B. Association of Optimal Lamotrigine Serum Levels and Therapeutic Efficacy in Mood Disorders: A Systematic Review. J Clin Psychopharmacol. 2021 Aug 26 [Epub ahead of print]
    View PubMed
55. Singh B, Port JD, Voort JLV, Coombes BJ, Geske JR, Lanza IR, Morgan RJ, Frye MA. A preliminary study of the association of increased anterior cingulate gamma-aminobutyric acid with remission of depression after ketamine administration. Psychiatry Res. 2021 Jul; 301:113953 Epub 2021 Apr 20
    View PubMed
56. Palmer BA, Pahwa M, Geske JR, Kung S, Nassan M, Schak KM, Alarcon RD, Frye MA, Singh B. Self-report screening instruments differentiate bipolar disorder and borderline personality disorder. Brain Behav. 2021 Jul; 11 (7):e02201 Epub 2021 May 30
    View PubMed
57. Seshadri A, Wermers ME, Habermann TJ, Singh B. Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis. Prim Care Companion CNS Disord. 2021 Jun 24; 23 (4) Epub 2021 June 24
    View PubMed
58. Pattan V, Singh B, Abdelmoneim SS, Gopinath C, Sundaresh V. Lithium-Induced Hyperparathyroidism: An Ill-defined Territory. Psychopharmacol Bull. 2021 Jun 1; 51 (3):65-71
    View PubMed
59. Parikh SV, Lopez D, Vande Voort JL, Rico J, Achtyes E, Coryell W, Goddard A, Goes F, Greden JF, Singh B, Kaplin A, Frye MA, Maixner D, Watson B, Drake K, Tarnal V, Riva-Posse P, Bobo WV, Bio-K Study Team Team. Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer. Psychopharmacol Bull. 2021 Jun 1; 51 (3):109-124
    View PubMed
60. Hu Y, Kung S, Ozerdem A, Vande Voort JL, Singh B, McDonald WM, Riva-Posse P, Frye MA. Hypomania associated with high dose ketamine treatment. Bipolar Disord. 2021 Jun; 23 (4):426-428 Epub 2021 Feb 24
    View PubMed
61. Joseph B, Nandakumar AL, Ahmed AT, Gopal N, Murad MH, Frye MA, Tobin WO, Singh B. Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis. Evid Based Ment Health. 2021 May; 24 (2):88-94 Epub 2020 Dec 16
    View PubMed
62. Seshadri A, Orth SS, Adaji A, Singh B, Clark MM, Frye MA, McGillivray J, Fuller-Tyszkiewicz M. Mindfulness-Based Cognitive Therapy, Acceptance and Commitment Therapy, and Positive Psychotherapy for Major Depression. Am J Psychother. 2021 Mar 1; 74 (1):4-12 Epub 2020 Sept 28
    View PubMed
63. Joseph B, Parsaik AK, Ahmed AT, Erwin PJ, Singh B. A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression. J Clin Psychopharmacol. 2021 Jan/Feb 01; 41(1):71-75.
    View PubMed
64. Seshadri A, Adaji A, Orth SS, Singh B, Clark MM, Frye MA, Fuller-Tyszkiewicz M, McGillivray J. Exercise, Yoga, and Tai Chi for Treatment of Major Depressive Disorder in Outpatient Settings: A Systematic Review and Meta-Analysis. Prim Care Companion CNS Disord 2020 Dec 31; 23 (1)
    View PubMed
65. Ho AM, Coombes BJ, Nguyen TTL, Liu D, McElroy SL, Singh B, Nassan M, Colby CL, Larrabee BR, Weinshilboum RM, Frye MA, Biernacka JM. Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association Study. Clin Pharmacol Ther. 2020 Dec; 108 (6):1233-1242 Epub 2020 Aug 07
    View PubMed
66. Pahwa M, Nunez NA, Joseph B, Seshadri A, Gerberi DJ, Frye MA, Singh B. Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2020 Sep 14; 50 (4):118-136
    View PubMed
67. Nunez NA, Joseph B, Pahwa M, Seshadri A, Prokop LJ, Kung S, Schak KM, Vande Voort JL, Frye MA, Singh B. An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis. Psychopharmacol Bull. 2020 Sep 14; 50 (4):137-163
    View PubMed
68. Cuellar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, Nunez NA, Cabello-Arreola A, Coombes BJ, Prieto M, Betcher HK, Moore KM, Winham SJ, Biernacka JM, Frye MA. Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. Int J Bipolar Disord. 2020 Jul 4; 8 (1):23 Epub 2020 July 04
    View PubMed
69. Romo-Nava F, Blom TJ, Guerdjikova A, Winham SJ, Cuellar-Barboza AB, Nunez NA, Singh B, Biernacka JM, Frye MA, McElroy SL. Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder. Acta Psychiatr Scand. 2020 Jul; 142 (1):58-65 Epub 2020 May 30
    View PubMed
70. Singh B, Nunez NA, Schock L, Joseph B, Kohoutek B, Roerig JL. Lithium continuation for a patient with bipolar disorder and chronic kidney disease. Bipolar Disord. 2020 May; 22 (3):316-318 Epub 2020 Apr 20
    View PubMed
71. Nunez NA, Singh B, Romo-Nava F, Joseph B, Veldic M, Cuellar-Barboza A, Cabello Arreola A, Vande Voort JL, Croarkin P, Moore KM, Biernacka J, McElroy SL, Frye MA. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials. Bipolar Disord. 2020 Mar; 22 (2):109-120 Epub 2020 Jan 07
    View PubMed
72. Singh B, Hughes AJ, Roerig JL. Comfort Level and Barriers to the Appropriate Use of Clozapine: a Preliminary Survey of US Psychiatric Residents. Acad Psychiatry. 2020 Feb; 44 (1):53-58 Epub 2019 Nov 11
    View PubMed
73. Frye MA, Coombes BJ, McElroy SL, Jones-Brando L, Bond DJ, Veldic M, Romo-Nava F, Bobo WV, Singh B, Colby C, Skime MK, Biernacka JM, Yolken R. Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder. JAMA Psychiatry. 2019 Dec 1; 76 (12):1285-1293
    View PubMed
74. Singh B, Bobo WV, Rasmussen KG, Stoppel CJ, Rico JA Jr, Schak KM, Biernacka JM, Frye MA, Vande Voort JL. The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine. J Clin Psychiatry 2019 Nov 12; 80 (6)
    View PubMed
75. Veldic M, Ahmed AT, Blacker CJ, Geske JR, Biernacka JM, Borreggine KL, Moore KM, Prieto ML, Vande Voort JL, Croarkin PE, Hoberg AA, Kung S, Alarcon RD, Keeth N, Singh B, Bobo WV, Frye MA. Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications. Front Pharmacol. 2019; 10:83 Epub 2019 Feb 19
    View PubMed
76. Morgan RJ, Singh B. Reality testing of the efficacy of tDCS on auditory hallucinations in schizophrenia. Schizophr Res 2018 Sep; 199:454-455
    View PubMed
77. Zhao N, Xu J, Singh B, Yu X, Wu T, Huang Y. Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2016 Aug 04; (8)(8)CD010726.
    View PubMed
78. Vashistha V, Singh B, Kaur S, Prokop LJ, Kaushik D. The Effects of Exercise on Fatigue, Quality of Life, and Psychological Function for Men with Prostate Cancer: Systematic Review and Meta-analyses. Eur Urol Focus. 2016 Aug; 2 (3):284-295 Epub 2016 Mar 09
    View PubMed
79. Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK. Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. Prim Care Companion CNS Disord. 2016 Jul 28; 18 (4) Epub 2016 July 28
    View PubMed
80. Parsaik AK, Mascarenhas SS, Khosh-Chashm D, Hashmi A, John V, Okusaga O, Singh B. Mortality associated with anxiolytic and hypnotic drugs-A systematic review and meta-analysis. Aust N Z J Psychiatry. 2016 Jun; 50: (6)520-33.
    View PubMed
81. Parsaik AK, Mascarenhas SS, Hashmi A, Prokop LJ, John V, Okusaga O, Singh B. Role of Botulinum Toxin in Depression. J Psychiatr Pract. 2016 Mar; 22 (2):99-110
    View PubMed
82. Nusair A, Singh B, Ding S, Gajic O, Li G.. Interrater variability in identifying Ventilator Associated Pneumonia using six different definitions Marshall Journal of Medicine.2015;1:(1)
    
83. Singh K, Hibbert B, Singh B, Carson K, Premaratne M, Le May M, Chong AY, Arstall M, So D. Meta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality? Eur Heart J Cardiovasc Pharmacother. 2015 Oct; 1: (4)220-8.
    View PubMed
84. Ahmed AH, Giri J, Kashyap R, Singh B, Dong Y, Kilickaya O, Erwin PJ, Murad MH, Pickering BW. Outcome of adverse events and medical errors in the intensive care unit: a systematic review and meta-analysis. Am J Med Qual. 2015 Jan-Feb; 30(1):23-30. Epub 2013 Dec 19.
    View PubMed
85. Akhoundi A, Singh B, Vela M, Chaudhary S, Monaghan M, Wilson GA, Dillon JJ, Cartin-Ceba R, Lieske JC, Gajic O, Kashani K. Incidence of Adverse Events during Continuous Renal Replacement Therapy. Blood Purif. 2015; 39 (4):333-9 Epub 2015 May 22
    View PubMed
86. Malik SA, Malik S, Dowsley TF, Singh B. Left Ventricular Thrombus as a Complication of Clozapine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Case Rep Cardiol. 2015; 2015:835952.
    View PubMed
87. Singh K, Parsaik A, Singh B. Recurrent takotsubo cardiomyopathy : variable pattern of ventricular involvement. Herz. 2014 Dec; 39: (8)963-7.
    View PubMed
88. Parsaik AK, Singh B, Murad MH, Singh K, Mascarenhas SS, Williams MD, Lapid MI, Richardson JW, West CP, Rummans TA. Statins use and risk of depression: a systematic review and meta-analysis. J Affect Disord. 2014 May; 160:62-7 Epub 2013 Dec 17
    View PubMed
89. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, Geda YE, Christianson TJ, Pankratz VS, Petersen RC. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014 May; 71 (5):581-8
    View PubMed
90. Singh K, Carson K, Shah R, Sawhney G, Singh B, Parsaik A, Gilutz H, Usmani Z, Horowitz J. Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. Am J Cardiol. 2014 Apr 15; 113: (8)1420-8.
    View PubMed
91. Parsaik AK, Singh B, Roberts RO, Pankratz S, Edwards KK, Geda YE, Gharib H, Boeve BF, Knopman DS, Petersen RC. Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study. JAMA Neurol. 2014 Feb; 71(2):201-7.
    View PubMed
92. Singh B, Tiwari AK, Singh K, Singh SK, Ahmed A, Erwin PJ, Franco PM. beta2 agonist for the treatment of acute lung injury: a systematic review and meta-analysis. Respir Care. 2014 Feb; 59 (2):288-96 Epub 2013 June 18
    View PubMed
93. Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO. Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis. 2014; 39 (2):271-82
    View PubMed
94. Ahmed AH, Litell JM, Malinchoc M, Kashyap R, Schiller HJ, Pannu SR, Singh B, Li G, Gajic O. The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a population-based study. Crit Care Med. 2014 Jan; 42 (1):31-9
    View PubMed
95. Singh B, Iqbal FM, Sunkavalli KK, Chawla B. A unique paradoxical reaction to tuberculosis therapy: case report and brief review of the literature. Am J Ther. 2013 Nov-Dec; 20: (6)e706-9.
    View PubMed
96. Singh B, Parsaik AK, Mielke MM, Roberts RO, Scanlon PD, Geda YE, Pankratz VS, Christianson T, Yawn BP, Petersen RC. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc. 2013 Nov; 88 (11):1222-30
    View PubMed
97. Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, Murad MH. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013 Nov; 28 (11):1496-503 Epub 2013 June 18
    View PubMed
98. Singh B, Parsaik AK, Prokop LJ, Mittal MK. Endovascular therapy for acute ischemic stroke: a systematic review and meta-analysis. Mayo Clin Proc. 2013 Oct; 88 (10):1056-65
    View PubMed
99. Sunkavalli KK, Iqbal FM, Singh B, Koneru J. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature. Am J Ther. 2013 Sep-Oct; 20: (5)569-71.
    View PubMed
100. Singh B, Mommer SK, Erwin PJ, Mascarenhas SS, Parsaik AK. Pulmonary embolism rule-out criteria (PERC) in pulmonary embolism--revisited: a systematic review and meta-analysis. Emerg Med J. 2013 Sep; 30 (9):701-6 Epub 2012 Oct 04
     View PubMed
101. Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G. Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study. Chest. 2013 May; 143 (5):1235-1242
     View PubMed
102. Wang S, Singh B, Tian L, Biehl M, Krastev IL, Kojicic M, Li G. Epidemiology of noninvasive mechanical ventilation in acute respiratory failure--a retrospective population-based study. BMC Emerg Med. 2013 Apr 09; 13:6.
     View PubMed
103. Zhao N, Xu J, Singh B, Wu T, Yu X. Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery Cochrane Database of Systematic Reviews. 2013; 2013 (8):CD010726
     
104. Singh B, Murad MH, Prokop LJ, Erwin PJ, Wang Z, Mommer SK, Mascarenhas SS, Parsaik AK. Meta-analysis of Glasgow coma scale and simplified motor score in predicting traumatic brain injury outcomes. Brain Inj. 2013; 27 (3):293-300 Epub 2012 Dec 19
     View PubMed
105. Wang B, Guo Q, Peng Y, Lu J, Singh B, Hua B. Association of AGT M235T and ACE I/D polymorphisms with the risk of ischemic stroke: meta-analysis in Han Chinese population. J Neurol Sci. 2012 Sep 15; 320(1-2):79-84. Epub 2012 Jul 15.
     View PubMed
106. Singh B, Singh A, Ahmed A, Wilson GA, Pickering BW, Herasevich V, Gajic O, Li G. Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records. Mayo Clin Proc. 2012 Sep; 87 (9):817-24
     View PubMed
107. Singh B, Parsaik AK, Agarwal D, Surana A, Mascarenhas SS, Chandra S. Diagnostic accuracy of pulmonary embolism rule-out criteria: a systematic review and meta-analysis. Ann Emerg Med. 2012 Jun; 59 (6):517-20.e1-4 Epub 2011 Dec 15
     View PubMed
108. Awasthi D, Tiwari AK, Upadhyaya A, Singh B, Tomar GS. Ketotic hyperglycemia with movement disorder. J Emerg Trauma Shock. 2012 Jan; 5: (1)90-1.
     View PubMed
109. Martinez Hernandez C, Sunkavalli KK, Nanda NC, Lohiya V, Martinez Sanchez A, Iniguez K, Singh A, Nabavizadeh F, Singh B. Incremental role of three-dimensional over two-dimensional ultrasound in the assessment of traumatic peripheral arteriovenous fistula. Echocardiography. 2011 Apr; 28: (4)480-1.
     View PubMed
110. Assudani J, Singh B, Samar A, Pannu J, Singh A, Nabavizadeh F, Singh P, Sunkavalli KK, Nanda NC. Live/real time three-dimensional transesophageal echocardiographic findings in caseous mitral annular calcification. Echocardiography. 2010 Oct; 27: (9)1147-50.
     View PubMed
111. Aggarwal H, Singh B, Wade MJ, Davies JE, Nanda NC. Usefulness of live/real time three-dimensional transthoracic echocardiography in the assessment of descending thoracic aorta graft dehiscence. Echocardiography. 2010 Jul; 27: (6)722-3.
     View PubMed
112. Singh B, Kuruba M, Singh P, Hernandez CM, Waseemuddin M, Nanda NC. Live/Real time three-dimensional transthoracic echocardiographic assessment of inferior vena cava and hepatic vein thrombosis in sickle cell disease. Echocardiography. 2010 May; 27: (5)594-6.
     View PubMed
113. Singh P, Hernandez CM, Singh B, Kuruba M, Samar A, Nanda NC. Live/real time three-dimensional transthoracic echocardiography in the evaluation of post traumatic acquired thoracic aortic coarctation. Echocardiography. 2010 Apr; 27: (4)470-2.
     View PubMed